Projects funded by the NCN


Information on the principal investigator and host institution

Information of the project and the call

Keywords

Equipment

Delete all

How HPV16 infection influences EGFR/PI3K/AKT/mTOR pathway in squamous cell cancer of head and neck?

2016/21/N/NZ5/00227

Keywords:

head and neck cancer HPV EGFR/PI3K/AKT/mTOR pathway PCR

Descriptors:

  • NZ5_7: Human disease treatment
  • NZ5_1: Etiology of human diseases

Panel:

NZ5 - Human and animal noninfectious diseases: etiology, mechanisms, diagnosis and treatment of diseases, poisonings and injuries (without neurological diseases)

Host institution :

Narodowy Instytut Onkologii im. Marii Skłodowskiej-Curie - Państwowy Instytut Badawczy, Oddział w Krakowie

woj. mazowieckie

Other projects carried out by the institution 

Principal investigator (from the host institution):

Anna Janecka-Widła 

Number of co-investigators in the project: 3

Call: PRELUDIUM 11 - announced on 2016-03-15

Amount awarded: 150 000 PLN

Project start date (Y-m-d): 2017-03-07

Project end date (Y-m-d): 2021-03-06

Project duration:: 48 months (the same as in the proposal)

Project status: Project settled

Project description

Download the project description in a pdf file

Note - project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.

Information in the final report

  • Publication in academic press/journals (3)
  • Articles in post-conference publications (3)
  1. Active HPV infection and its influence on survival in head and neck squamous-cell cancer
    Authors:
    Janecka-Widła A, Mucha-Małecka A, Majchrzyk K, Halaszka K, Przewoźnik M, Słonina D, Biesaga B
    Academic press:
    Journal of Cancer Research and Clinical Oncology (rok: 2020, tom: 146(7), strony: 1677–1692), Wydawca: Springer
    Status:
    Published
    DOI:
    10.1007/s00432-020-03218-6 - link to the publication
  2. EGFR/PI3K/Akt/mTOR pathway in head and neck squamous cell carcinoma patients with different HPV status
    Authors:
    Janecka-Widła A, Majchrzyk K, Mucha-Małecka A, Biesaga B
    Academic press:
    Polish Journal of Pathology (rok: 2021, tom: 73(4), strony: 45310), Wydawca: Termedia
    Status:
    Published
    DOI:
    10.5114/pjp.2021.113073 - link to the publication
  3. Prognostic potential of Akt, pAkt(Ser473) and pAkt(Thr308) immunoreactivity in relation to HPV prevalence in head and neck squamous cell carcinoma patients
    Authors:
    Janecka-Widła A, Majchrzyk K, Mucha-Małecka A, Słonina D, Biesaga B
    Academic press:
    Pathology - Research and Practice (rok: 2022, tom: 229, strony: 153684), Wydawca: Elsevier
    Status:
    Published
    DOI:
    10.1016/j.prp.2021.153684 - link to the publication
  1. Wpływ HPV16 na ekspresję EGFR, AKT i PTEN w płaskonabłonkowych nowotworach terenu głowy i szyi u chorych z południowej i centralnej Polski
    Authors:
    Janecka-Widła A, Mucha-Małecka A, Halaszka K, Przewoźnik M, Szostek S, Kowalczyk A, Słonina D, Biesaga B
    Conference:
    XX Kongres Polskiego Towarzystwa Onkologii Klinicznej (rok: 2017, ), Wydawca: Via Medica sp. z o.o.
    Data:
    konferencja 14 - 16 września
    Status:
    Published
  2. The prevalence of HPV in head and neck squamous cell cancer tissues of patients from South-Central Poland
    Authors:
    Janecka-Widła A, Mucha-Małecka A, Przewoźnik M, Halaszka K, Szostek S, Kowalczyk A, Słonina D, Biesaga B
    Conference:
    EUROGIN - International Multidisciplinary HPV Congress (rok: 2017, ), Wydawca: brak danych
    Data:
    konferencja 8-11 październik
    Status:
    Published
  3. Akt and pAkt expression and their prognostic significance in HPV16 positive and HPV negative head and neck squamous cell cancer patients
    Authors:
    Janecka-Widła A, Majchrzyk K, Mucha-Małecka A, Biesaga B
    Conference:
    34th International Papillomavirus Conference (IPVC 2021) (rok: 2021, ), Wydawca: International Papillomavirus Society
    Data:
    konferencja 15-19 listopad
    Status:
    Published